Werner Alfons Scherbaum

Werner Alfons Scherbaum's AcademicInfluence.com Rankings

Philosophy

#8647

World Rank

#12063

Historical Rank

Logic

#5672

World Rank

#7089

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Werner Alfons Scherbaum Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Werner Alfons Scherbaum's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial (2005) (3960)
Intraadrenal interactions in the regulation of adrenocortical steroidogenesis. (1998) (606)
Human adipocytes secrete mineralocorticoid-releasing factors (2003) (424)
Molecular mechanisms of insulin resistance (2005) (351)
Evidence for a Novel Peripheral Action of Leptin as a Metabolic Signal to the Adrenal Gland: Leptin Inhibits Cortisol Release Directly (1997) (344)
Self-monitoring of blood glucose in type 2 diabetes and long-term outcome: an epidemiological cohort study (2006) (291)
Corticotropin-releasing hormone: An autocrine hormone that promotes lipogenesis in human sebocytes (2002) (273)
Development of type 1 diabetes despite severe hereditary B-cell deficiency. (2001) (243)
Adult-Onset Autoimmune Diabetes in Europe Is Prevalent With a Broad Clinical Phenotype (2013) (203)
Biocompatibility of various collagen membranes in cultures of human PDL fibroblasts and human osteoblast-like cells. (2004) (199)
Insulin and the CNS: effects on food intake, memory, and endocrine parameters and the role of intranasal insulin administration in humans (2004) (197)
The Deutsche Nicotinamide Intervention Study: an attempt to prevent type 1 diabetes. DENIS Group. (1998) (195)
Interleukin-6 and the interleukin-6 receptor in the human adrenal gland: expression and effects on steroidogenesis. (1997) (187)
Expression of Ob receptor in normal human adrenals: differential regulation of adrenocortical and adrenomedullary function by leptin. (1998) (185)
Immunohistochemical and ultrastructural localization of leptin and leptin receptor in human white adipose tissue and differentiating human adipose cells in primary culture. (2000) (181)
Association of systemic chemokine concentrations with impaired glucose tolerance and type 2 diabetes: results from the Cooperative Health Research in the Region of Augsburg Survey S4 (KORA S4). (2005) (179)
Influence of different treatment approaches on the removal of early plaque biofilms and the viability of SAOS2 osteoblasts grown on titanium implants (2005) (168)
Adult-Onset Autoimmune Diabetes in Europe Is Prevalent With a Broad Clinical Phenotype: Action LADA 7. Diabetes Care 2013;36:908–913 (2014) (167)
Long-term anticonvulsant therapy leads to low bone mineral density--evidence for direct drug effects of phenytoin and carbamazepine on human osteoblast-like cells. (2012) (166)
Human breast adipocytes express interleukin-6 (IL-6) and its receptor system: increased IL-6 production by beta-adrenergic activation and effects of IL-6 on adipocyte function. (2001) (164)
The HOPE (Heart Outcomes Prevention Evaluation) Study: the design of a large, simple randomized trial of an angiotensin-converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events. The HOPE study investigators. (1996) (155)
Titre and combination of ICA and autoantibodies to glutamic acid decarboxylase discriminate two clinically distinct types of latent autoimmune diabetes in adults (LADA) (2001) (155)
Intimate contact of chromaffin and cortical cells within the human adrenal gland forms the cellular basis for important intraadrenal interactions. (1994) (151)
Immunological heterogeneity in Type I diabetes: presence of distinct autoantibody patterns in patients with acute onset and slowly progressive disease (1998) (151)
Effects of splanchnic nerve stimulation on the adrenal cortex may be mediated by chromaffin cells in a paracrine manner. (1990) (143)
Different cytokine mRNA profiles in Graves' disease, Hashimoto's thyroiditis, and nonautoimmune thyroid disorders determined by quantitative reverse transcriptase polymerase chain reaction (RT-PCR). (1996) (140)
Development of type 1 diabetes despite severe hereditary B lymphocyte deficiency: No pathogenic role of B lymphocytes (2000) (135)
CD97: a dedifferentiation marker in human thyroid carcinomas. (1997) (135)
Introducing a simplified approach to insulin therapy in type 2 diabetes: a comparison of two single‐dose regimens of insulin glulisine plus insulin glargine and oral antidiabetic drugs (2008) (132)
Efficacy and tolerability of vildagliptin in drug‐naïve patients with type 2 diabetes and mild hyperglycaemia * (2008) (126)
Evidence that vildagliptin attenuates deterioration of glycaemic control during 2‐year treatment of patients with type 2 diabetes and mild hyperglycaemia * (2008) (122)
Diabetes classification: grey zones, sound and smoke: Action LADA 1 (2008) (122)
AUTOANTIBODIES TO VASOPRESSIN CELLS IN IDIOPATHIC DIABETES INSIPIDUS: EVIDENCE FOR AN AUTOIMMUNE VARIANT (1983) (121)
Diabetes Mellitus Type 2 (2007) (117)
Somatic Mutations in the Thyrotropin Receptor Gene and Not in the Gsα Protein Gene in 31 Toxic Thyroid Nodules1 (1997) (111)
Effects of an Er:YAG laser and the Vector ultrasonic system on the biocompatibility of titanium implants in cultures of human osteoblast-like cells. (2003) (105)
Immunotherapy for medullary thyroid carcinoma by dendritic cell vaccination. (2001) (104)
Comparison of octreotide acetate LAR and lanreotide SR in patients with acromegaly (2000) (103)
In vivo effects of an Er:YAG Laser, an ultrasonic system and scaling and root planing on the biocompatibility of periodontally diseased root surfaces in cultures of human PDL fibroblasts (2003) (97)
Characterization of the influence of vildagliptin on model-assessed -cell function in patients with type 2 diabetes and mild hyperglycemia. (2008) (97)
Levels of autoantibodies against human TSH receptor predict relapse of hyperthyroidism in Graves' disease. (2004) (94)
IFN-α Skews Monocytes into CD56+-Expressing Dendritic Cells with Potent Functional Activities In Vitro and In Vivo1 (2008) (92)
Human monoclonal islet cell antibodies from a patient with insulin-dependent diabetes mellitus reveal glutamate decarboxylase as the target antigen. (1992) (92)
Pro- and anti-inflammatory cytokines in latent autoimmune diabetes in adults, type 1 and type 2 diabetes patients: Action LADA 4 (2011) (92)
Impaired adrenal stress response in Toll-like receptor 2-deficient mice. (2004) (91)
Distinct Genetic and Immunological Features in Patients With Onset of IDDM Before and After Age 40 (1997) (86)
Sequence homology of the diabetes-associated autoantigen glutamate decarboxylase with coxsackie B4-2C protein and heat shock protein 60 mediates no molecular mimicry of autoantibodies (1994) (83)
Regulation of insulin secretion, glucokinase gene transcription and beta cell proliferation by adipocyte-derived Wnt signalling molecules (2007) (82)
Metabolic efficacy and safety of once-daily pioglitazone monotherapy in patients with type 2 diabetes: a double-blind, placebo-controlled study. (2002) (82)
Combined screening for autoantibodies to IA-2 and antibodies to glutamic acid decarboxylase in first degree relatives of patients with IDDM (1996) (82)
Psychotherapy intervention to reduce depressive symptoms in patients with diabetic foot syndrome (2008) (81)
Variants of the PPARG, IGF2BP2, CDKAL1, HHEX, and TCF7L2 genes confer risk of type 2 diabetes independently of BMI in the German KORA studies. (2008) (80)
Sporadic congenital hyperthyroidism due to a spontaneous germline mutation in the thyrotropin receptor gene. (1997) (80)
Age‐dependent decline of β‐cell function in type 1 diabetes after diagnosis: a multi‐centre longitudinal study (2014) (80)
Corticotropin-releasing hormone system in human adipose tissue. (2004) (78)
Adipocyte-derived products induce the transcription of the StAR promoter and stimulate aldosterone and cortisol secretion from adrenocortical cells through the Wnt-signaling pathway (2007) (78)
Identification of constitutively activating somatic thyrotropin receptor mutations in a subset of toxic multinodular goiters. (1997) (77)
Fat Cells May Be the Obesity–Hypertension Link: Human Adipogenic Factors Stimulate Aldosterone Secretion from Adrenocortical Cells (2004) (74)
Interleukin-6 messenger ribonucleic acid expression in human adrenal gland in vivo: new clue to a paracrine or autocrine regulation of adrenal function. (1994) (74)
Antibodies to human recombinant tissue transglutaminase measured by radioligand assay: evidence for high diagnostic sensitivity for celiac disease. (1999) (73)
Regulation of adrenocortical function by cytokines--relevance for immune-endocrine interaction. (1998) (73)
Leptin down-regulates the steroid producing system in the adrenal. (1998) (73)
Diabetes mellitus Typ 2 (2002) (72)
Detecting TSH-receptor antibodies with the recombinant TBII assay: technical and clinical evaluation. (2000) (70)
Relation of fibre intake to HbA1c and the prevalence of severe ketoacidosis and severe hypoglycaemia (1998) (67)
A phytosterol-enriched spread improves the lipid profile of subjects with type 2 diabetes mellitus (2003) (66)
Expression of tumour necrosis factor‐alpha (TNF‐α) mRNA and protein in pathological thyroid tissue and carcinoma cell lines (1996) (65)
Human adrenal cells express tumor necrosis factor-alpha messenger ribonucleic acid: evidence for paracrine control of adrenal function. (1996) (65)
Plasma catecholamines in patients with Addison's disease (1995) (64)
Adipocyte-secreted factors increase osteoblast proliferation and the OPG/RANKL ratio to influence osteoclast formation (2012) (63)
Osteoporosis screening in systemic lupus erythematosus: impact of disease duration and organ damage (2001) (63)
Somatic mutations in the thyrotropin receptor gene and not in the Gs alpha protein gene in 31 toxic thyroid nodules. (1997) (62)
Sympathoadrenal regulation of adrenocortical steroidogenesis. (1995) (62)
Serum thrombomodulin. A novel marker of disease activity in systemic lupus erythematosus. (1994) (60)
Thyrotropin receptor autoantibodies in Graves' disease (2005) (60)
Application of a bioassay with CHO cells for the routine detection of stimulating and blocking autoantibodies to the TSH-receptor. (1998) (60)
Role of the vasoactive intestinal peptide in a neuroendocrine regulation of the adrenal cortex. (1991) (60)
AUTOANTIBODIES TO PITUITARY CORTICOTROPIN-PRODUCING CELLS: POSSIBLE MARKER FOR UNFAVOURABLE OUTCOME AFTER PITUITARY MICROSURGERY FOR CUSHING'S DISEASE (1987) (59)
Chemokines and autoimmune thyroid diseases. (2008) (58)
Serum selenium levels in patients with remission and relapse of graves' disease. (2007) (57)
Neuroendocrine neoplasms of the gastrointestinal tract. (2011) (57)
Effects of a novel corticotropin-releasing-hormone receptor type I antagonist on human adrenal function (2000) (57)
Clinical value of the first automated TSH receptor autoantibody assay for the diagnosis of Graves’ disease (GD): an international multicentre trial (2009) (56)
Elevated serum levels and reduced immunohistochemical expression of thrombomodulin in active ulcerative colitis. (1997) (56)
COXSACKIE-B-VIRUS-SPECIFIC IgM RESPONSES, COMPLEMENT-FIXING ISLET-CELL ANTIBODIES, HLA DR ANTIGENS, AND C-PEPTIDE SECRETION IN INSULIN-DEPENDENT DIABETES MELLITUS (1985) (55)
Induction of cellular immunity in a parathyroid carcinoma treated with tumor lysate-pulsed dendritic cells. (2000) (55)
Relevance of major histocompatibility complex class II expression as a hallmark for the cellular differentiation in the human adrenal cortex. (1997) (54)
Association of serum levels of retinol-binding protein 4 with male sex but not with insulin resistance in obese patients (2010) (53)
Human B cells secreting immunoglobulin G to glutamic acid decarboxylase-65 from a nondiabetic patient with multiple autoantibodies and Graves' disease: a comparison with those present in type 1 diabetes. (1997) (53)
Evidence of a combined cytotoxic thyroglobulin and thyroperoxidase epitope-specific cellular immunity in Hashimoto's thyroiditis. (2012) (53)
Morphological evidence for a close interaction of chromaffin cells with cortical cells within the adrenal gland (1991) (53)
Epidemiology and Immunogenetic Background of Islet Cell Antibody–Positive Nondiabetic Schoolchildren: Ulm-Frankfurt Population Study (1991) (52)
Morphological and functional studies of the paracrine interaction between cortex and medulla in the adrenal gland (1997) (50)
Regulation of adrenal steroidogenesis by adrenaline: expression of cytochrome P450 genes. (1992) (50)
Effect of the Frequency of Self-Monitoring Blood Glucose in Patients with Type 2 Diabetes Treated with Oral Antidiabetic Drugs—A Multi-Centre, Randomized Controlled Trial (2008) (49)
The value of training in communication skills for continuing medical education. (2011) (49)
Lymphocytes stimulate dehydroepiandrosterone production through direct cellular contact with adrenal zona reticularis cells: a novel mechanism of immune-endocrine interaction. (1999) (48)
Role of Interleukin‐6 in Stress Response in Normal and Tumorous Adrenal Cells and during Chronic Inflammation (2002) (47)
Pancreatic NOD beta cells express MHC class II protein and the frequency of I-Ag7 mRNA-expressing beta cells strongly increases during progression to autoimmune diabetes (2003) (47)
MHC class II expression--a new tool to assess dignity in adrenocortical tumours. (1996) (47)
Differential regulation of apoptosis in the normal human adrenal gland. (1996) (47)
Wisconsin card sorting test synchronizes the prefrontal, temporal and posterior association cortex in different frequency ranges and extensions (2002) (47)
Direct effects of interleukin-6 on human adrenal cells. (1996) (47)
The serum growth hormone-binding protein is reduced in young patients with insulin-dependent diabetes mellitus. (1993) (46)
Calcitonin-specific antitumor immunity in medullary thyroid carcinoma following dendritic cell vaccination (2002) (45)
Serum thrombomodulin—a reliable marker of disease activity in systemic lupus erythematosus (SLE): advantage over established serological parameters to indicate disease activity (2000) (45)
Change in patients’ body weight after 12 months of treatment with glimepiride or glibenclamide in Type 2 diabetes: a multicentre retrolective cohort study (2003) (44)
mRNA levels of membrane-type 1 matrix metalloproteinase (MT1-MMP), MMP-2, and MMP-9 and of their inhibitors TIMP-2 and TIMP-3 in normal thyrocytes and thyroid carcinoma cell lines. (1998) (44)
Pathophysiological aspects of Wnt-signaling in endocrine disease. (2009) (43)
Baculovirus-mediated expression of human 65 kDa and 67 kDa glutamic acid decarboxylases in SF9 insect cells and their relevance in diagnosis of insulin-dependent diabetes mellitus. (1993) (43)
BMI is an important driver of β-cell loss in type 1 diabetes upon diagnosis in 10 to 18-year-old children. (2014) (43)
Epidemiology of complications and total treatment costs from diagnosis of Type 2 diabetes in Germany (ROSSO 4). (2007) (43)
The metabolic syndrome sensitizes leukocytes for glucose-induced immune gene expression (2007) (43)
Autoantibodies to human tissue transgutaminase identify silent coeliac disease in Type I diabetes (1999) (42)
Classically conditioned responses following repeated insulin and glucose administration in humans (2000) (42)
The Fourth International Serum Exchange Workshop to standardize cytoplasmic islet cell antibodies (1991) (41)
The diabetic charcot foot: MRI discloses bone stress injury as trigger mechanism of neuroarthropathy. (2006) (41)
Assessment of precision, concordance, specificity, and sensitivity of islet cell antibody measurement in 41 assays (1990) (41)
Prevalence of chronic complications, metabolic control and nutritional intake in type 1 diabetes: comparison between different European regions. EURODIAB Complications Study group. (1999) (41)
Dendritic cell immunotherapy in a neuroendocrine pancreas carcinoma (2001) (40)
Binding of antithyrotropin receptor autoantibodies in Graves' disease serum to nascent, in vitro translated thyrotropin receptor: ability to map epitopes recognized by antibodies. (1996) (40)
Increased serum concentrations of adhesion molecules but not of chemokines in patients with Type 2 diabetes compared with patients with Type 1 diabetes and latent autoimmune diabetes in adult age: Action LADA 5 (2012) (40)
Adrenaline stimulates cholesterol side-chain cleavage cytochrome P450 mRNA accumulation in bovine adrenocortical cells. (1991) (40)
Macrophages within the human adrenal gland (1994) (39)
Using the World Wide Web--a new approach to risk identification of diabetes mellitus. (1997) (39)
Autoantibodies to adrenal cytochrome P450 antigens in isolated Addison's disease and autoimmune polyendocrine syndrome type II. (2009) (39)
Localization and regulation of pancreatic selenoprotein P. (2012) (39)
Response of human monocyte‐derived dendritic cells to immunostimulatory DNA (2000) (38)
Role of the novel mTOR inhibitor RAD001 (everolimus) in anaplastic thyroid cancer. (2009) (38)
Intensive glycemic control lowers plasma visfatin levels in patients with type 2 diabetes. (2008) (38)
Detection of Ob-receptor in human adrenal neoplasms and effect of leptin on adrenal cell proliferation. (1999) (37)
The serum sodium to urinary sodium to (serum potassium)2 to urinary potassium (SUSPPUP) ratio in patients with primary aldosteronism (2009) (37)
Association between antibodies to the MR 67,000 isoform of glutamate decarboxylase (GAD) and type 1 (insulin-dependent) diabetes mellitus with coexisting autoimmune polyendocrine syndrome type II. (1994) (37)
[Value of biochemical and imaging procedures for the diagnosis and prognosis of acute pancreatitis--results of a prospective clinical study]. (1986) (37)
Dendritic cell vaccination induces tumor epitope-specific Th1 immune response in medullary thyroid carcinoma. (2008) (36)
Antibodies to the tyrosine phosphatase-like protein IA-2 are highly associated with IDDM, but not with autoimmune endocrine diseases or stiff man syndrome. (1997) (36)
Low frequency of autoantibodies to the human Na(+)/I(-) symporter in patients with autoimmune thyroid disease. (2000) (36)
The Fourth International Workshop on the Standardisation of Insulin Autoantibody Measurement (2004) (36)
Sympathoadrenal system and immune system in the regulation of adrenocortical function. (1996) (36)
Human thyroid carcinoma cell lines and normal thyrocytes: expression and regulation of matrix metalloproteinase-1 and tissue matrix metalloproteinase inhibitor-1 messenger-RNA and protein. (1997) (35)
Diabetes insipidus in children. IV. A possible autoimmune type with vasopressin cell antibodies. (1985) (34)
Human immunoglobulin G autoantibodies to the thyrotropin receptor from Epstein-Barr virus-transformed B lymphocytes: characterization by immunoprecipitation with recombinant antigen and biological activity. (1996) (34)
Effect of enamel matrix protein derivative on the attachment, proliferation, and viability of human SaOs2 osteoblasts on titanium implants (2004) (33)
Comparison of M22-based ELISA and human-TSH-receptor-based luminescence assay for the measurement of thyrotropin receptor antibodies in patients with thyroid diseases. (2008) (33)
A simplified procedure for the isolation of immunoglobulins from human serum using a novel type of thiophilic gel at low salt concentration. (1998) (32)
Technical evaluation of the first fully automated assay for the detection of TSH receptor autoantibodies. (2009) (32)
Sympathoadrenal regulation of adrenal androstenedione release. (1994) (32)
Direct binding of thyrotropin receptor autoantibody to in vitro translated thyrotropin receptor: a comparison to radioreceptor assay and thyroid stimulating bioassay. (1999) (31)
Differential gene expression profile of glucocorticoids, testosterone, and dehydroepiandrosterone in human cells. (2001) (31)
Inverse Relationship Between Organ-Specific Autoantibodies and Systemic Immune Mediators in Type 1 Diabetes and Type 2 Diabetes: Action LADA 11 (2016) (31)
Circulating chemokines in patients with autoimmune thyroid diseases. (2008) (30)
[Depression, anxiety, quality of life and type D pattern among inpatients suffering from diabetic foot syndrome]. (2008) (30)
Comparison of the Saline Infusion Test and the Fludrocortisone Suppression Test for the Diagnosis of Primary Aldosteronism (2012) (30)
Associations of fat and cholesterol intake with serum lipid levels and cardiovascular disease: the EURODIAB IDDM Complications Study. (2009) (30)
Interaction of endothelial cells and neutrophils in vitro: kinetics of thrombomodulin, intercellular adhesion molecule‐1 (ICAM‐1), E‐selectin, and vascular cell adhesion molecule‐1 (VCAM‐1): implications for the relevance as serological disease activity markers in vasculitides (2000) (30)
Improved prediction of relapse of Graves' thyrotoxicosis by combined determination of TSH receptor and thyroperoxidase antibodies. (2007) (30)
Mapping of novel autoreactive epitopes of the diabetes‐associated autoantigen IA‐2 (2000) (30)
Unconditioned and conditioned effects of intranasally administered insulin vs placebo in healthy men: a randomised controlled trial (2011) (29)
Dendritic cell immunotherapy in disseminated parathyroid carcinoma (1999) (28)
Expression of cytokines in the thyroid: thyrocytes as potential cytokine producers. (2009) (28)
CITED2 is expressed in human adrenocortical cells and regulated by basic fibroblast growth factor. (2007) (28)
Functional central hypothyroidism in the elderly (2008) (27)
Dendritic Cell Vaccination with Xenogenic Polypeptide Hormone Induces Tumor Rejection in Neuroendocrine Cancer (2008) (27)
Classical conditioning and conditionability of insulin and glucose effects in healthy humans (2004) (27)
Exendin-4 upregulates the expression of Wnt-4, a novel regulator of pancreatic β-cell proliferation. (2011) (27)
Subclinical hypothyroidism and the prevalence of the metabolic syndrome. (2011) (26)
Chromaffin cell function and structure is impaired in corticotropin-releasing hormone receptor type 1-null mice (2002) (26)
Characterization of a linear epitope within the human pancreatic 64-kDa glutamic acid decarboxylase and its autoimmune recognition by sera from insulin-dependent diabetes mellitus patients. (1993) (26)
Effect of proinflammatory cytokines on gene expression of the diabetes-associated autoantigen IA-2 in INS-1 cells. (2002) (25)
Chronic inflammation and hemodialysis reduce immune competence of peripheral blood leukocytes in end-stage renal failure patients. (2005) (25)
Morphological changes in adrenals from victims of suicide in relation to altered apoptosis. (1998) (25)
Corticotropin-Releasing Hormone Receptor Expression on Normal and Tumorous Human Adrenocortical Cells (2006) (25)
Dendritic cells as potential adjuvant for immunotherapy in adrenocortical carcinoma (2006) (25)
Substrate specificity for the detection of autoantibodies to anterior pituitary cells in human sera. (1990) (24)
Immunoregulatory natural killer cells suppress autoimmunity by down-regulating antigen-specific CD8+ T cells in mice. (2012) (24)
Prevalence of autoantibodies to endocrine organs in girls with Ullrich-Turner syndrome aged 5-14 years. (1992) (24)
Comparison between Long-Menu and Open-Ended Questions in computerized medical assessments. A randomized controlled trial (2006) (24)
Unconditioned and conditioned effects of intravenous insulin and glucose on heart rate variability in healthy men (2011) (24)
Prevalence of impaired glucose regulation in German school-leaving students (2007) (23)
Increased body fat mass and suppression of circulating leptin levels in response to hypersecretion of epinephrine in phenylethanolamine-N-methyltransferase (PNMT)-overexpressing mice. (2000) (23)
Basal and postglucagon C-peptide levels in Ethiopians with diabetes. (2002) (22)
Soluble Fas is increased in hyperthyroidism independent of the underlying thyroid disease. (2001) (22)
Re-evaluation of eye muscle autoantibody determination in Graves' ophthalmopathy: failure to detect a specific antigen by use of enzyme-linked immunosorbent assay, indirect immunofluorescence, and immunoblotting techniques. (1989) (22)
Glutamic acid decarboxylase (GAD) autoantibodies are additional predictive markers of Type 1 (insulin-dependent) diabetes mellitus in high risk individuals (1992) (22)
Sporadic solitary aldosterone- and cortisol-co-secreting adenomas: endocrine, histological and genetic findings in a subtype of primary aldosteronism (2010) (22)
Fas-Mediated apoptosis is inhibited by TSH and iodine in moderate concentrations in primary human thyrocytes in vitro. (1999) (22)
Adrenocortical atrophy of hypophysectomized rats can be reduced by corticotropin-releasing hormone (CRH) (1990) (22)
Autoimmune diagnostics in diabetes mellitus (2006) (21)
Relevance of TSH receptor stimulating and blocking autoantibody measurement for the prediction of relapse in Graves' disease. (2005) (21)
Role of Autoimmunity in Central Diabetes insipidus (1985) (21)
Efficacy and tolerability of vildagliptin in drug-naïve patients with type 2 diabetes (T2DM) and mild hyperglycemia (2008) (21)
Regulation of the diabetes-associated autoantigen IA-2 in INS-1 pancreatic beta-cells. (2000) (21)
11-Keto-β-Boswellic Acids Prevent Development of Autoimmune Reactions, Insulitis and Reduce Hyperglycemia During Induction of Multiple Low-Dose Streptozotocin (MLD-STZ) Diabetes in Mice (2015) (20)
Modern concepts for the prediction of type 1 diabetes. (2001) (20)
Morphological and hormonal changes following vasectomy in rats, suggesting a functional role for Leydig-cell associated macrophages. (1991) (20)
Activated and interferon-gamma producing thyroid-derived T cells are detected in Graves' disease, thyroid autonomy as well as in non-toxic multinodular goiter. (1996) (20)
Pheochromocytoma during pregnancy: laparoscopic and conventional surgical treatment of two cases. (2004) (19)
Adrenal pheochromocytoma with contralateral cortisol-producing adrenal adenoma: diagnostic and therapeutic management. (2005) (19)
On the clinical importance of thyroid microsomal and thyroglobulin antibody determination. (1987) (19)
Ceruloplasmin expression in rat liver cells is attenuated by insulin: role of FoxO transcription factors. (2011) (19)
Fifth International Serum Exchange Workshop for Insulin Autoantibody (IAA) Standardization (1992) (19)
Megaoesophagus in a patient with autoimmune polyglandular syndrome Type II (1996) (19)
Increased aldosterone/renin quotient in obese hypertensive women: a novel role for low-density lipoproteins? (2006) (18)
[Effect of pancreatin on diabetes mellitus in chronic pancreatitis]. (1990) (18)
Helpful diagnostic markers of steroidogenesis for defining hyperandrogenemia in hirsute women (2008) (18)
Dendritic cell immunotherapy induces antitumour response in parathyroid carcinoma and neuroendocrine pancreas carcinoma. (1999) (18)
Henoch-Schönlein purpura with ileitis terminalis (1993) (18)
Implementing disease management programs for type 2 diabetes in Germany. (2006) (17)
Are we ready to predict and prevent endocrine/organ specific autoimmune diseases? (2002) (17)
Long latency between GAD-antibody detection and development of limbic encephalitis – a case report (2015) (17)
Evaluation of apoptotic parameters in normal and neoplastic human adrenal. (1996) (17)
[CASUS model trial. A computer-assisted author system for problem-oriented learning in medicine]. (1996) (17)
Interferon-alpha antibodies in autoimmune diseases. (1989) (17)
GAD65 is recognized by T-cells, but not by antibodies from NOD-mice. (1994) (16)
Two amino acids in glutamic acid decarboxylase act in concert for maintainance of conformational determinants recognised by Type I diabetic autoantibodies (2000) (16)
Four-year evolution of insulin regimens, glycaemic control, hypoglycaemia and body weight after starting insulin therapy in type 2 diabetes across three continents (2013) (16)
Indicators of mineralocorticoid excess in the evaluation of primary aldosteronism (2010) (16)
Evaluation of diagnostic relevance of mRNA levels in peripheral blood: predictive value for mortality in hemodialysis patients. (2004) (16)
IA-2 autoantibodies restricted to the IgG4 subclass are associated with protection from type 1 diabetes. (2002) (16)
Cost-effectiveness of pioglitazone in type 2 diabetes patients with a history of macrovascular disease: a German perspective (2009) (15)
Polychlorinated biphenyls affect thyroid function and induce autoimmunity in Sprague-Dawley rats. (2009) (15)
[Use of the internet for health care information: results from a national telephone survey]. (2004) (15)
Angiotensin II regulates both adrenocortical and adrenomedullary function in isolated perfused pig adrenals (1996) (15)
HLA-A2 Phenotype may be Protective Against Graves’ Disease but not Against Hashimoto’s Thyroiditis in Caucasians (2012) (14)
Hypercortisolism caused by ritonavir associated inhibition of CYP 3A4 under inhalative glucocorticoid therapy. 2 case reports and a review of the literature. (2012) (14)
An ELISA method for the detection of autoantibodies to adrenal cortex. (1985) (14)
Control of CYP11B2/CYP11B1 Expression Ratio and Consequences for the Zonation of the Adrenal Cortex (2012) (14)
Identification of occult metastases of medullary thyroid carcinoma by pentagastrin-stimulated intravenous calcitonin sampling followed by targeted surgery (2007) (14)
Expression of interleukin-1 in human pheochromocytoma (1996) (14)
Vasoactive intestinal peptide (VIP) stimulates androstenedione release in isolated perfused pig adrenals. (1993) (14)
Myocardial infarction and stroke in early years after diagnosis of type 2 diabetes: risk factors and relation to self-monitoring of blood glucose. (2009) (14)
Acquired and inherited lipodystrophies. (2004) (14)
Ultrastructural dynamics of mitochondrial morphology in varying functional forms of human adrenal cortical adenoma. (1996) (13)
Functional changes in microcirculation during hyperbaric and normobaric oxygen therapy. (2009) (13)
A progressive increase in cardiovascular risk assessed by coronary angiography in non-diabetic patients at sub-diabetic glucose levels (2011) (13)
Autoantibodies to ICA12 (SOX-13) are not specific for Type I diabetes (2000) (13)
Isolation of IgG islet cell autoantibody-producing B lymphocytes from the peripheral blood of type 1 diabetic patients and an ICA-positive non-diabetic individual. (1989) (13)
Expression and mutation analysis of the tyrosine kinase c-kit in poorly differentiated and anaplastic thyroid carcinoma. (2008) (13)
Effects of an Er:YAG laser on mitochondrial activity of human osteosarcoma–derived osteoblasts in vitro (2004) (13)
Association of impaired glucose metabolism in morbid obesity with hypoadiponectinaemia. (2008) (13)
Autoantibodies to adrenal medullary and thyroid calcitonin cells in type I diabetes mellitus--a prospective study. (1988) (12)
Myasthenia gravis: Overlap with ‘polyendocrine’ autoimmunity (1983) (12)
Statins decrease the aberrant HLA-DR expression on thyrocytes from patients with Hashimoto's thyroiditis. (2008) (12)
[Diabetic complications. Micro and macroangiopathic end-organ damage]. (2003) (12)
A pre-task resting condition neither ‘baseline’ nor ‘zero’ (2005) (12)
T cell reactivity to DR*0401- and DQ*0302-binding peptides of the putative autoantigen IA-2 in type 1 diabetes. (2009) (12)
Increased numbers of tumor-lysing monocytes in cancer patients (2011) (12)
Carcinogenic hypergastrinemia: signet-ring cell carcinoma in a patient with multiple endocrine neoplasia type 1 with Zollinger-Ellison's syndrome. (2007) (12)
35th Annual meeting of the European Association for the Study of Diabetes. Brussels, Belgium, 28 September-2 October, 1999. Abstracts. (1999) (11)
Ultrastructural evidence for cortico-chromaffin hybrid cells in rat adrenals? (1991) (11)
A new mutation in the menin gene causes the multiple endocrine neoplasia type 1 syndrome with adrenocortical carcinoma (2011) (11)
Four-year evolution of insulin regimens, glycaemic control, hypoglycaemia and body weight after starting insulin therapy in type 2 diabetes across three continents. (2015) (11)
Anti-perinuclear and rheumatoid factor in different forms of autoimmune thyroid disease. (1984) (11)
Unlocking the opportunity of tight glycaemic control (2005) (11)
Circulating intercellular adhesion molecule 1 as a new activity marker in patients with systemic lupus erythematosus (1993) (11)
Immunological and clinical characterization of patients with untreated euthyroid and hypothyroid autoimmune thyroiditis. Antibody spectrum, response to TRH and clinical study. (1982) (11)
Differential regulation of granulocyte-macrophage colony-stimulating factor mRNA and protein expression in human thyrocytes and thyroid-derived fibroblasts by interleukin-1α and tumour necrosis factor-α (1996) (11)
A Case of Catecholamine and Glucocorticoid Excess Syndrome Due to a Corticotropin‐Secreting Paraganglioma (2006) (10)
The endothelium secretes interleukin-6 (IL-6) and induces IL-6 and aldosterone generation by adrenocortical cells. (2008) (10)
Effect of cytokines on proliferation of Epstein Barr virus-transformed B lymphocytes. (1990) (10)
Insulin therapy in Europe (2002) (10)
Interferon-α antibodies in autoimmune diseases (1989) (10)
Regulation of sodium-iodide-symporter gene expression in human thyrocytes measured by real-time polymerase chain reaction. (2003) (10)
Comparison of a solid phase human- versus porcine- thyrotropin receptor-based immunoassay for the measurement of thyrotropin receptor antibodies in patients with thyroid diseases. (2008) (10)
Altered Disease Course after Initiation of Self-Monitoring of Blood Glucose in Noninsulin-Treated Type 2 Diabetes (ROSSO 3) (2007) (9)
Detection of autoantibodies to the diabetes-associated antigen IA-2 by a sensitive enzyme-linked immunosorbent assay. (1999) (9)
Comparison of a new anti-glutamic acid decarboxylase (GAD) enzyme-linked immunosorbent assay (ELISA) with radioimmunoassay methods: a multicenter study. (1997) (9)
Evidence for the involvement of endothelial cell products in adrenal CITED2 expression (2008) (9)
11-Keto-β-Boswellic Acid Inhibits Lymphocyte (CD3) Infiltration Into Pancreatic Islets of Young None Obese Diabetic (NOD) Mice (2017) (9)
Amino acid-modified calcitonin immunization induces tumor epitope-specific immunity in a transgenic mouse model for medullary thyroid carcinoma. (2008) (9)
Cytoplasmic islet cell antibodies (ICA): towards a molecular understanding of the autoantigens (1994) (9)
Chromogranin A as potential target for immunotherapy of malignant pheochromocytoma (2011) (9)
The combination of antibodies to GAD-65 and IA-2ic can replace the islet-cell antibody assay to identify subjects at risk of type 1 diabetes mellitus. (1999) (8)
Autoimmune thyroid disease. (1987) (8)
Gap junctions in the adrenal cortex. (1993) (8)
Vasopressin cell surface antibodies in central diabetes insipidus detected on cultured human foetal hypothalamus. (1985) (8)
Type 2 Diabetes Phenotype and Progression is Significantly Different if Diagnosed before versus after 65 Years of Age (2008) (8)
The effect of corticotropin-releasing hormone (CRH) on the adrenal medulla in hypophysectomized rats. (1998) (8)
Antibodies to the M(r) 64,000 (64K) protein in islet cell antibody positive non-diabetic individuals indicate high risk for impaired beta-cell function. (1992) (8)
Antibodies to the Mr 64,000 (64K) protein in islet cell antibody positive non-diabetic individuals indicate high risk for impaired Beta-cell function (1992) (8)
The effects of the endothelium on adrenal steroidogenesis and growth are mainly mediated by proteins other than endothelin-1. (2010) (8)
Evidence for the Involvement of an Anion Exchanger in Cortisol Release from Bovine Adrenocortical Cells (1996) (7)
Dendritic Cell Vaccination: Potential Immunotherapy for Adrenocortical Carcinoma (2004) (7)
[Novel aspects in the mechanisms of steroid diabetes and the regulation of hepatic glucose production by insulin and steroids]. (2003) (7)
Recombinant IA-2 expressed in E. coli can be used for the routine detection of autoantibodies in Type-I diabetes. (1998) (7)
Etiology and pathogenesis of type 1 diabetes. (1992) (7)
No expression of ir-ACTH on stimulated peripheral blood leukocytes. (1987) (7)
[Progress in molecular medicine: "laser capture microdissection"]. (1998) (7)
Nestin as a marker in the classification of adrenocortical tumors. (2009) (7)
Atrial natriuretic peptide-like immunoreactive material (ANP-LI) is released from the adrenal gland by splanchnic nerve stimulation. (2009) (6)
Reproducibility of Elecsys anti-TSHR test results in a lot-to-lot comparison. (2010) (6)
[Ectopic production of chorionic gonadotropin in apudomas (author's transl)]. (1978) (6)
Differential regulation of granulocyte-macrophage colony-stimulating factor mRNA and protein expression in human thyrocytes and thyroid-derived fibroblasts by interleukin-1 alpha and tumor necrosis factor-alpha. (1996) (6)
IGF-1, IGFBP-3, and cancer risk (2004) (6)
Immunotherapy and gene therapy of thyroid cancer. (2004) (6)
T cell autoimmunity to glutamic acid decarboxylase in human insulin-dependent diabetes mellitus. (1996) (6)
Dendritic cell-based immunotherapy in thyroid malignancies. (2004) (6)
Organ-specific autoantibodies in non-organ-specific autoimmune diseases with special reference to rheumatoid arthritis (2004) (6)
Griseofulvin Inhibits the Growth of Adrenocortical Cancer Cells In Vitro (2012) (6)
Time dependent C-peptide decline in 4411 patients with recent onset type 1 diabetes followed for up to 10 years: a meta-analysis from 8 European centres (2011) (6)
Are Type 2 Diabetes Patients Who Self-Monitor Blood Glucose Special? The Role of Confounders in the Observational ROSSO Study (2009) (5)
The level and the persistence of islet cell antibodies in healthy schoolchildren are associated with polymorphic residues of the HLA-DQ beta chain. (1991) (5)
Role of ovarian sex steroids in the regulation of thyrotropin (TSH) secretion of hypogonadal women. (1992) (5)
Tietze's syndrome — a chameleon under the thoracic abdominal pain syndroms (1988) (5)
Cellular models for the analysis of signaling by protein kinase B and the forkhead transcription factor FKHR (Foxo1a) (2004) (5)
Determination of islet cell antibodies using an ELISA system with a preparation of rat insulinoma (RIN A2) cells. (1989) (5)
Antineutrophil cytoplasmic autoantibodies (ANCA) in acute pancreatitis. (1992) (5)
Spontaneous transient remission of disseminated histiocytosis X during pregnancy (2005) (5)
[Immunogenetics of type I (insulin dependent) diabetes mellitus]. (1987) (5)
Cellular and humoral autoimmunity in insulin-dependent diabetes mellitus. (2009) (5)
Cushing's disease in a patient with steroid 21-hydroxylase deficiency. (2011) (5)
[The quality of CME questions as a component part of continuing medical education--an empirical study]. (2007) (4)
High frequency of diabetes-specific autoantibodies in parents of children with type 1 diabetes. DENIS study group. (1999) (4)
THE SHORT SYNACTHEN TEST IN THE EVALUATION OF ADRENAL MASSES IN PATIENTS WITH MALIGNANCIES (2002) (4)
Improving clinical utility of GAD65 autoantibodies by electrochemiluminescence assay and clinical phenotype when identifying autoimmune adult-onset diabetes (2021) (4)
Administration of d-alpha-tocopherol in patients with insulin-dependent diabetes mellitus (1996) (4)
[Management of diabetic patients in inpatient nursing care facilities in the Heinsberg district]. (2000) (4)
Non-human primate pancreas as a substrate for the detection of islet-cell antibodies in human sera. (1989) (4)
[Drug therapy of endocrine neoplasms. Part II: Malignant gastrinomas, insulinomas, glucagonomas, carcinoids and other tumors]. (2000) (4)
[Model trial: use and evaluation of a problem-oriented learning program in internal medicine]. (1999) (4)
AUTOANTIBODIES IN RHEUMATIC DISEASES (1980) (4)
Spontaneous remission of primary hyperparathyroidism. (2007) (4)
Endothelin-1 and Adrenomedullin Plasma Levels After Exposure to Fludrocortisone, Dexamethasone, and Spironolactone (2012) (3)
Diabetes Update 2017 (2017) (3)
[Care of elderly diabetics by ambulatory nursing in the Heinsberg region]. (2008) (3)
Hypoparathyroidism and autoimmune polyendocrine syndromes. (2004) (3)
35th Annual Meeting of the European Association for the Study of Diabetes (2016) (3)
[Recurrent erythema nodosum after administration of a low-dose oral contraceptive drug]. (1994) (3)
Reactivity and intracellular location of the ACTH cell autoantigen in human fetal and adult anterior pituitary tissue. (1993) (3)
[Significance of thyroid antibodies for diagnosis and follow-up of thyroid diseases]. (1995) (3)
Intrapancreatic adipocyte deposition in a mouse model of the metabolic syndrome. (2008) (3)
[Infectious complications in immunosuppressed patients after kidney transplantation]. (1988) (3)
[Bariatric surgery and diabetes mellitus: pioneering studies from 2012 and consequences for treatment strategies]. (2013) (2)
α-Glukosidase-Hemmer und Thiazolidindione (Glitazone) (2016) (2)
DIABETES-MELLITUS - INTRODUCTION TO THE TOPIC (1987) (2)
[The heart and metabolic syndrome]. (1999) (2)
Helpful diagnostic markers for defining hyperandrogenemia in hirsute women (2007) (2)
[B-mode ultrasound and modern Doppler ultrasound methods in diseases of the thyroid gland and parathyroid glands]. (1998) (2)
False positives on both dexamethasone testing and urinary free cortisol in women on oral contraception: dose–response effects. (2013) (2)
[Autoimmune form of central diabetes insipidus with antibodies against vasopressin-producing hypothalamic cells]. (1983) (2)
[Autoimmune polyendocrinopathies. Pathogenic hypotheses]. (1986) (2)
Evidence-based Guideline by the German Diabetes Association and the German Geriatric Society Diagnosis , Treatment and Follow-up of Diabetes mellitus in the Elderly (2006) (2)
The CB-1 receptor antagonist rimonabant modulates the interaction between adipocytes and pancreatic beta-cells in vitro. (2010) (2)
[Type 1, type 2 diabetes, MODY and LADA. Making a differential diagnosis]. (2001) (2)
A man with diabetes and a swollen leg (1999) (2)
[Cytoplasmic islet cell antibodies and GAD antibodies in diagnosis of diabetes]. (1995) (2)
Reply to comment on: Martin S, Schneider B, Heinemann L et al (2006) Self-monitoring of blood glucose in type 2 diabetes and long-term outcome: an epidemiological cohort study. Diabetologia 49:271–278 (2006) (2)
Iodine-induced thyroiditis in the non-obese diabetic (NOD) mouse--more questions than answers. (2009) (2)
[Pharmacotherapy of obesity]. (2006) (2)
The adrenal gland and ACTH. (1996) (2)
Autoimmune Thyroiditis: Approaches Towards its Etiological Differentiation (1991) (2)
Autoantikörper beim Diabetes mellitus: Diagnostischer Stellenwert. Autoantibodies in Diabetes Mellitus: Diagnostic Value (1999) (2)
[Diagnosis of autoimmune insulitis before the clinical manifestation of type I diabetes mellitus]. (1987) (2)
CD 97 : A Dedifferentiation Marker in Human Thyroid Carcinomas 1 (2006) (2)
Empowering the citizen (2001) (1)
[Evidence-based medicine in diabetes mellitus. Expert guidelines a the basis for medical practice and information for patients and the population in general]. (2002) (1)
[Therapy of diabetes mellitus in old age]. (2015) (1)
Do patients with type 2 diabetes on peritoneal dialysis need less insulin if they are given rosiglitazone? (2006) (1)
[Detection of a previously unrecognized type 2 diabetes using a risk questionnaire. Efficiency for general population screening]. (2006) (1)
[The effectiveness of CME -- quality improvement through differentiated advanced medical education research]. (2009) (1)
[Determining the current position regarding the value of pioglitazone for the therapy of diabetes]. (2007) (1)
Typ-2-Diabetes – Update 2018 (2018) (1)
Chromogranin a as potential tumour antigen in pheochromocytoma. (2009) (1)
[Epidemiologic studies of the recognition of the preclinical phase of type I diabetes in school children]. (1990) (1)
[Selective blocking of thyroid adenomas using small doses of perchlorate]. (1978) (1)
Sporadic solitary aldosterone- and cortisol-cosecreting adenomas: a subtype of primary aldosteronism (2010) (1)
IMMUNE MARKERS IN POPULATION SURVEYS AND FAMILY STUDIES (1994) (1)
[Immunology of type-1 diabetes. The initial stages in a causal therapy]. (1986) (1)
Professor Ernst-Friedrich Pfeiffer (1997) (1)
[Esophago-tracheal fistula in malignant non-Hodgkin lymphoma]. (1984) (1)
Kardiovaskuläre Prävention durch intensivierte Insulintherapie (2006) (1)
In vitro synthesized TSH receptor as a tool for autoantibody detection. (2009) (1)
[Care of persons with diabetes in Germany--where do we stand today?]. (2003) (1)
Indirect immunofluorescence in the study and diagnosis of organ-specific autoimmune disease. (1986) (1)
Care provision of persons with diabetes inGermany:what is the present position? (2003) (1)
[Stiff-man syndrome from the perspective of internal medicine and immunology]. (2000) (1)
[Diabetes emergencies]. (2014) (1)
[Granulation tissue induced by vacuum-therapy on the exposed chondral part of the condyle of femur after disarticulation of the knee]. (2006) (1)
[Clinical and laboratory chemical studies of the incidence and extent of diabetic cheiropathy in childhood and adolescence]. (1989) (1)
Substitution therapy after surgery for autonomous adenomas. (2009) (1)
Identification of occult metastases in medullary thyroid carcinoma via pentagastrin-stimulated intravenous calcitonin sampling followed by targeted surgery (2007) (1)
Islet enhancer vildagliptin: a powerful partner with metformin for the treatment of patients with type 2 diabetes (2009) (1)
Editorial: Diabetes mellitus – neue Therapiekonzepte (2007) (0)
A novel direct link between obesity and hypertension: Human adipocytes secrete mineralocorticoid releasing factors (2004) (0)
[Subgroups of myasthenia gravis. Association of the early form with HLA B8/DR3]. (1983) (0)
[Significance of autoantibodies in the diagnosis of endocrine diseases]. (1981) (0)
Glycolipids and complete Freund's adjuvant cause insulitis in rats. (1991) (0)
Erratum to: Pro- and anti-inflammatory cytokines in latent autoimmune diabetes in adults, type 1 and type 2 diabetes patients: Action LADA 4 (2011) (0)
Potent Functional Activities In Vitro and In CD56+-Expressing Dendritic Cells with Skews Monocytes into α IFN- (2013) (0)
Self-monitoring of blood glucose in type 2 diabetes: Steps toward consensus [2] (2007) (0)
Cardiovascular outcomes and their relationship to risk factors and baseline disease over 4 years when starting insulin in type 2 diabetes: the CREDIT study (2014) (0)
[Corticoid resistance in boeck's disease]. (1978) (0)
Impaired activation of proteinkinase B by insulin in primary cultured hepatocytes from NZO-mice, a model system for the metabolic syndrome (2005) (0)
Oxytocin-producing pancreatic carcinoma presenting as ectopic ACTH syndrome (1989) (0)
Multicentric brown tumors in primary hyperparathyroidism two years after surgery for giant cell granuloma of the nose (2007) (0)
Adrenal non-producing adenomas show indirect signs of glucocorticoid excess and hypercortisolism correlates with differential blood counts (2010) (0)
Diabetes Update 2021 (2021) (0)
Acute renal failure in carcinoid syndrome crisis (2004) (0)
The sodium to urinary sodium to potassium to urinary potassium (SUSPUP) ratio in primary aldosteronism (2008) (0)
Signet ring carcinoma in Zollinger-Ellison Syndrom: the role of E-cadherin and gastrin in the pathogenesis of the disease (2004) (0)
[Autoimmune thyroid diseases. Recent aspects of the pathogenesis and diagnosis]. (1984) (0)
A mutation IVS12 as-2, A>G heterozygous associated with osteogenesis imperfecta type 1 phenotype – a case report (2007) (0)
[Growth factor substitution after radical removal of craniopharyngioma]. (1997) (0)
Adipocyte-derived factors activate Wnt-signalling in pancreatic beta-cells (2005) (0)
Effects of endothelial cell products on the proliferation of human adrenocortical cancer cells (2006) (0)
[Rheumatoid factors in Basedow's disease]. (1978) (0)
Clinical evaluation of 3rd generation assay for thyrotropin receptor autoantibodies in autoimmune thyroid diseases (2008) (0)
Diabetes Update 2016 (2016) (0)
Hypokalemia associated with partial paralysis due to thyrotoxicosis (2006) (0)
Fat cell secretory products induce the transcription of the StAR promoter through the Wnt-signaling pathway (2006) (0)
Blocking enzyme-linked immunosorbent assay for the detection of autoantibodies to adrenal cortex (1985) (0)
[Current concepts of autoimmune polyendocrinopathies]. (1985) (0)
[Autoimmunity and internal secretion]. (1987) (0)
[Significant weight reduction by diet normalizes metabolic function in obesity and Type 2 diabetes to the same extent as gastric bypass]. (2020) (0)
11 Autoimmune thyroid diseases (2012) (0)
[Emphasis on diabetes mellitus]. (1998) (0)
[Diabetology 2008]. (2008) (0)
[Prevention of diabetes mellitus type 1]. (2005) (0)
[Diabetology 2007]. (2007) (0)
The German Diabetes Association German College for Psychosomatic Medicine Evidence-based Guidelines of the German Diabetes Association : Psychosocial Factors and Diabetes Mellitus (2004) (0)
Foreword by the Editors (2021) (0)
Contents Vol. 82, 2005 (2006) (0)
Special Topics Revisited (2007) (0)
How the workup of low renin hypertension lead to the diagnosis of SIADH (2008) (0)
[Prerenal kidney failure in type 1 diabetes mellitus]. (2003) (0)
Diabetes Update 2019 (2019) (0)
[The treatment of heel pressure ulcer with the vacuum therapy (v.a.C. system)]. (2004) (0)
Immunotherapy of Neuroendocrine Tumors (2004) (0)
[The value of bariatric surgery in the treatment of diabetes : The STAMPEDE study]. (2017) (0)
Induction of cytotoxic immunity by dendritic cell vaccination in patients with medullary thyroid carcinoma (2004) (0)
NOD β-cells express RANTES and may attract their own killers (2004) (0)
Peptidergic cells in mouse Langerhans islets express TNFalpha. (2003) (0)
Subject Index Vol. 82, 2005 (2006) (0)
[Clinical advances in diabetes]. (2006) (0)
Adipocytes induce insulin secretion and glucokinase gene transcription in pancreatic beta-cells through the Wnt-signalling pathway (2007) (0)
H4 – Diabetes mellitus (2007) (0)
Subject Index Vol. 54, 1991 (1991) (0)
Aktuelle Strategien des Diabetesmanagement (2004) (0)
Expression of CITED2 in human adrenal tissues (2005) (0)
Adipocyte-derived factors activate Wnt-signaling in beta-cells and induce beta-cell proliferation (2006) (0)
Addendum to: Diabetes and pregnancy-update 2020 Proposal for temporary changes to the recommendations for the diagnosis and care of pregnant women with diabetes during the COVID-19 pandemic (2020) (0)
CITED2 expression and its regulation in human adrenocortical cancer (2007) (0)
Diabetes-Update 2012 (2012) (0)
Diabetes Update 2008/2009 (2009) (0)
Diabetes Update 2014 – das spannendste Diabetes-Update aller Zeiten (2014) (0)
Contents, Vol. 54, 1991 (1991) (0)
Not a Population-Based Survey. (2017) (0)
Role of newly identified immunosuppressive NK cells in autoimmunity (2010) (0)
Typ-1-Diabetes (2004) (0)
[Clinical aspects of the immunopathogenesis of type I diabetes mellitus]. (1987) (0)
The World Wide Web: A new approach to world wide supply of epidemiological data on diabetes mellitus (1997) (0)
Erratum to: A new mutation in the menin gene causes the multiple endocrine neoplasia type 1 syndrome with adrenocortical carcinoma (2011) (0)
[Metformin and anesthesia--how great is the risk of lactic acidosis]. (2001) (0)
Diagnosis and treatment of thyroid diseases in the aging (1995) (0)
[The demonstration and specificity of autoreactive T-lymphocytes in type-1 diabetes]. (1997) (0)
Expression of the tyrosine kinase c-kit in anaplastic thyroid carcinoma and its clinical implication (2006) (0)
[Uncertainly after publications on glitazones. Elevated myocardial infarction risk is not a class effect]. (2007) (0)
Steroidogenic action of endothelial cell products on adrenocortical cells in vitro (2006) (0)
Autoantibodies to vasopressin secreting cells (AVP-¢) in children with idiopathic diabetes insipidus of central origin (1984) (0)
[Diabetology 2009]. (2009) (0)
Adipocyte-derived factors induce insulin secretion, glucokinase gene transcription and β-cell proliferation through activation of Wnt-Signaling (2006) (0)
[Supply of and participation in CME activities in the area served the north rhine chamber of physicians in Germany]. (2010) (0)
Combined antibody screening for detailed prediction of relapse in Graves' disease (2006) (0)
[Autoimmunologic phenomena in endocrinopathies - relevance to medical practice]. (1984) (0)
[Therapy of obesity with liraglutide. NN8022-1807 study]. (2010) (0)
Professor Sotorios Raptis (2017) (0)
Presence of corticotropin-releasing-hormone receptor on adrenocortical cells (2004) (0)
[Modification of heart failure risk by obesity. Selected aspects of the Framingham Study]. (2003) (0)
[Can insulin humalog be given during pregnancy?]. (2003) (0)
Diabetes Update 2021 (2021) (0)
Identification of HLA class II-specific calcitonin epitopes as potential targets for immunotherapy in medullary thyroid carcinoma (2005) (0)
Positive effect of human adipocyte-secreted factors on human osteoblast proliferation and the OPG/RANKL ratio in vitro (2010) (0)
Practical experience and recommendations for diabetes treatment. (2010) (0)
[Antibodies against thyroid microsomes and thyroglobulin in Basedow's disease and other diseases]. (1979) (0)
A Fresh Look at Autoantibodies in Chronic Pancreatitis (1990) (0)
[New successes with islet cell transplantation. Is insulin injection outmoded?. Interview by Dr. Bernhard Wiedemann]. (2000) (0)
Adrenal medulla in CRHR type 1-deficient mice (2002) (0)
The Endocrinology of Aging (1995) (0)
Biochemical and immunological markers for the outcome of acromegaly after pituitary surgery (1989) (0)
[Exact blood sugar measurements in premature and newborn infants]. (1998) (0)
Introduction by the Editor-in-Chief (2006) (0)
Dendritic cell vaccination with heteroclitic calcitonin peptides in a transgenic tumor mouse model for medullary thyroid carcinoma leads to specific anti-tumor immunity and diminished tumor outgrowth (2007) (0)
Increased aldosterone/renin ratio in obese hypertensive women (2005) (0)
Detection of vasopressin cell surface antibodies in patients with central diabetes insipidus (1986) (0)
[Optimal therapeutic strategy in type 2 diabetes mellitus]. (2009) (0)
Stem cell therapy after irradiation of a malignant asecretory pheochromocytoma – a case report (2006) (0)
PHL9/455: DIKS - The National Diabetes Information and Communication Server (1999) (0)
[Recent discoveries on the release and effects of vasopressin and oxytocin]. (1983) (0)
List of first-mentioned contributors (1995) (0)
MULTIPLE SYMMETRIC LIPOMATOSIS - CLINICAL CASE-REPORT WITH DISCUSSION OF PATHOGENETIC AND THERAPEUTIC CONCEPTS (1989) (0)
[Possibilities and value of immunofluorescence in the diagnosis of endocrine diseases]. (1983) (0)
Demonstration of the ACTH cell autoantigen on pituitary tissues (1988) (0)
Diabetes Update 2022 (2022) (0)
[Pilot study of controlled retrospective analysis (retrolective study design) of care for type 2 diabetics since 1990]. (2003) (0)
[The role of problem-oriented learning programs in internal medicine; comment]. (1999) (0)
[Drug therapy of endocrine neoplasms. Part I: Thyroid neoplasms, adrenal neoplasms and parathyroid neoplasms]. (2000) (0)
Relevance of TSH-Receptor stimulating and blocking autoantibody measurement for the prediction of relapse in Graves' disease (2005) (0)
MHC class II expression by beta cells in Type 1 diabetes: promoting or inhibiting the autoimmune process? A reply to D. W. R. Gray (2004) (0)
Sustained elevation of the proinflammatory cytokine IL-6 but not CRP in serum of type 2 diabetes patients with diabetic foot syndrome (2006) (0)
[Diabetes in pregnancy]. (2008) (0)
Tertiary hypercorticotropinism and Cushing's disease secondary to impaired 21-hydroxylation (2010) (0)
Monoclonal antibodies against islet cells of human pancreas. (1992) (0)
[Cardiovascular prophylaxis through intensified insulin treatment. EDIC (Epidemiology of Diabetes Interventions and Complications)]. (2006) (0)
[High HbA1c level in presence of good blood glucose control]. (2000) (0)
ELISA with a rat insulinoma (RIN A2) cell preparation as a tool for islet cell antibody screening programs (1990) (0)
[Cardiovascular effects of a lifestyle intervention in type 2 diabetes. The Look AHEAD (Action for Health in Diabetes) study]. (2014) (0)
Immunohistochemical and Ultrastructural Localization of Leptin and Leptin Receptor in Human White Adipose Tissue and Diff e r e n t i a t i n g Human Adipose Cells in Primary Culture (2000) (0)
Endothelial cell-derived products regulate [beta]-catenin-dependent transcription in human adrenocortical cells (2010) (0)
[Treatment of coma in diabetic ketoacidosis. Author reply]. (2015) (0)
„Highlights“ des Diabetes Update 2013 (2013) (0)
Ineffective fertilization therapy in patients with DAX-1 mutations (2004) (0)
Risk Assessment and Training about Type-2 Diabetes on the Internet (1997) (0)
10 Autoimmunity in diabetes mellitus (2012) (0)
Diabetes Insipidus Should Be Included. (2021) (0)
Wnt-signalling in human insulinomas (2012) (0)
CRH is an autocrine hormone for human sebocytes promoting lipogenesis (2002) (0)
[Micro-robot laboratory and computer-assisted work station with laser technology--a paradigm change for the clinical laboratory]. (1998) (0)
Hypoadiponectinemia but not activation of immune markers is associated with impaired glucose metabolism in morbidly obese patients (2008) (0)
Autoimmune diagnostics in diabetes mellitus 1 ) (2006) (0)
Hyperinsulinemic hypoglycemia due to polyclonal gammopathy with insulin autoantibodies (2006) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Werner Alfons Scherbaum?

Werner Alfons Scherbaum is affiliated with the following schools:

Heinrich Heine University Düsseldorf

Werner Alfons Scherbaum's Academic­Influence.com Rankings

Why Is Werner Alfons Scherbaum Influential?

Werner Alfons Scherbaum's Published Works

Published Works

What Schools Are Affiliated With Werner Alfons Scherbaum?

Werner Alfons Scherbaum's AcademicInfluence.com Rankings